HERON THERAPEUTICS, INC. /DE/ Cash Equivalents, at Carrying Value
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Cash Equivalents, at Carrying Value of $8.30 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-10
- 2026-06-30: Cash Equivalents, at Carrying Value $8.30M.
- 2026-03-31: Cash Equivalents, at Carrying Value $11.30M.
- 2025-12-31: Cash Equivalents, at Carrying Value $11.60M.
- 2025-09-30: Cash Equivalents, at Carrying Value $16.90M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $8.30M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $11.30M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $11.60M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $16.90M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $2.60M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $4.20M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $1.90M 10-K · filed 2026-02-26 | $900.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $11.50M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $4.20M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $5.20M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $5.30M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $5.60M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | $2.00M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.50M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $9.00M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $4.30M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $20.00M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $4.50M 10-K · filed 2023-03-29 | |
| 2021-03-31 | $5.00M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $55.90M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $7.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $7.60M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $103.30M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $15.00M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $11.80M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $20.00M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $265.80M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.10M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $16.40M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $18.00M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $2.80M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $49.40M 10-K · filed 2019-02-22 | |
| 2017-06-30 | $5.00M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $40.40M 10-Q · filed 2017-05-10 | |
| 2016-09-30 | $5.50M 10-Q · filed 2016-11-08 | |
| 2015-12-31 | $1.00M 10-K · filed 2017-02-23 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-04 | |
| 2013-12-31 | $0.00 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |